Ghent University Academic Bibliography

Your filters: cql: author="Annala, Matti" or (type any "bookEditor issueEditor" and editor="Annala, Matti")

Add to list
- Conference Paper
- C3
- open access
Genomic features of lung-recurrent hormone sensitive prostate cancer

Kim Van der Eecken, Nicolette Fonseca, Cameron Herberts, Sofie Verbeke (UGent) , Sarah Ng, Nicolaas Lumen (UGent) , Elie Ritch, Andrew Murtha, Cecily Bernales, Elena Schönlau, et al.

(2021) Belgian Week of Pathology, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Nicolette Fonseca, Kim Van der Eecken, Cameron Herberts, Sofie Verbeke (UGent) , Sarah Ng, Nicolaas Lumen (UGent) , Elie Ritch, Andrew Murtha, Cecily Bernales, Elena Schönlau, et al.

(2021) Global Congress on Prostate and Bladder Cancer 2021, Abstracts.
Add to list
- Conference Paper
- C3
Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der Eecken, Evan Warner, Nicolaas Lumen (UGent) , Matti Annala, Andrew Murtha, Elena Schönlau, Nicolette Fonseca, Cameron Herberts, Jan Vanwelkenhuyzen (UGent) , Wesley Verla (UGent) , et al.

(2020) Belgian Society for Human Genetics, 20th Annual meeting, Abstracts.
Add to list
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora Sundahl, Gillian Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) EUROPEAN UROLOGY. 75(5). p.707-711
Add to list
- Conference Paper
- C3
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian Vandekerkhove, Nora Sundahl, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(7, suppl. 5).

Academic Bibliography

Genomic features of lung-recurrent hormone sensitive prostate cancer

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Contents

Support

Contact